GNI Group Future Growth
Future criteria checks 5/6
GNI Group is forecast to grow earnings and revenue by 24.9% and 27.8% per annum respectively while EPS is expected to grow by 24.4% per annum.
Key information
24.9%
Earnings growth rate
24.4%
EPS growth rate
Biotechs earnings growth | 22.2% |
Revenue growth rate | 27.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 18 Mar 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 69,786 | 14,337 | N/A | 12,418 | 1 |
12/31/2025 | 50,401 | 10,405 | N/A | 9,882 | 1 |
12/31/2024 | 39,617 | 7,131 | N/A | 6,101 | 1 |
12/31/2023 | 26,010 | 8,094 | 4,474 | 6,549 | N/A |
9/30/2023 | 25,204 | 1,525 | 2,488 | 4,997 | N/A |
6/30/2023 | 23,360 | 1,370 | -1,540 | 876 | N/A |
3/31/2023 | 17,691 | 35 | -1,429 | 677 | N/A |
12/31/2022 | 17,418 | 388 | -1,546 | 393 | N/A |
9/30/2022 | 15,915 | 848 | -1,756 | -365 | N/A |
6/30/2022 | 14,379 | 801 | -1,219 | -159 | N/A |
3/31/2022 | 12,751 | 985 | -1,448 | -530 | N/A |
12/31/2021 | 12,690 | 1,066 | -141 | 552 | N/A |
9/30/2021 | 12,356 | 2,086 | 218 | 883 | N/A |
6/30/2021 | 11,858 | 1,955 | 1,318 | 1,669 | N/A |
3/31/2021 | 11,520 | 1,558 | 1,986 | 2,333 | N/A |
12/31/2020 | 9,773 | 1,258 | 1,020 | 1,377 | N/A |
9/30/2020 | 9,066 | 367 | 1,098 | 1,530 | N/A |
6/30/2020 | 8,407 | 247 | 691 | 1,289 | N/A |
3/31/2020 | 7,996 | 194 | 686 | 1,254 | N/A |
12/31/2019 | 7,446 | 181 | 176 | 788 | N/A |
9/30/2019 | 6,734 | 147 | 308 | 926 | N/A |
6/30/2019 | 6,279 | 154 | 86 | 789 | N/A |
3/31/2019 | 5,581 | 258 | -398 | 412 | N/A |
12/31/2018 | 5,018 | -200 | -224 | 621 | N/A |
9/30/2018 | 4,802 | 47 | -477 | 180 | N/A |
6/30/2018 | 4,095 | -130 | -728 | -116 | N/A |
3/31/2018 | 3,310 | -337 | -612 | -144 | N/A |
12/31/2017 | 2,648 | -175 | -796 | -476 | N/A |
9/30/2017 | 1,939 | -97 | N/A | -470 | N/A |
6/30/2017 | 1,473 | -111 | N/A | -284 | N/A |
3/31/2017 | 1,347 | -406 | N/A | -327 | N/A |
12/31/2016 | 1,306 | -513 | N/A | -518 | N/A |
9/30/2016 | 1,117 | -858 | N/A | N/A | N/A |
6/30/2016 | 1,073 | -956 | N/A | -514 | N/A |
3/31/2016 | 1,093 | -752 | N/A | N/A | N/A |
12/31/2015 | 1,016 | -623 | N/A | -382 | N/A |
9/30/2015 | 928 | -440 | N/A | N/A | N/A |
6/30/2015 | 814 | -360 | N/A | -574 | N/A |
3/31/2015 | 651 | -345 | N/A | N/A | N/A |
12/31/2014 | 474 | -327 | N/A | -567 | N/A |
9/30/2014 | 334 | -527 | N/A | N/A | N/A |
6/30/2014 | 254 | -787 | N/A | -862 | N/A |
3/31/2014 | 202 | -769 | N/A | N/A | N/A |
12/31/2013 | 183 | -730 | N/A | -662 | N/A |
9/30/2013 | 165 | -708 | N/A | N/A | N/A |
6/30/2013 | 147 | -462 | N/A | -292 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2160's forecast earnings growth (24.9% per year) is above the savings rate (0.2%).
Earnings vs Market: 2160's earnings (24.9% per year) are forecast to grow faster than the JP market (9.4% per year).
High Growth Earnings: 2160's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 2160's revenue (27.8% per year) is forecast to grow faster than the JP market (4.4% per year).
High Growth Revenue: 2160's revenue (27.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 2160's Return on Equity is forecast to be high in 3 years time